The results could pave the way for Datroway to supplant chemotherapy in certain triple-negative tumors, adding to existing ...

The findings are the latest setback for weight loss medicines that target a specific cannabinoid receptor and are meant to ...

Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that ...

The Italian drugmaker will pay as much as $115 million in upfront and near-term payments in a deal that gives it rights to a ...

Implementing artificial intelligence requires significant human labor and technical expertise, threatening to create a ...

The decision to clear another mifepristone generic sparked political backlash. Elsewhere, Medicare delayed a decision on whether to subject “combination” drugs to pricing negotiations, and a cancer ...

In a first-of-its-kind finding, Amgen’s PCSK9 drug protected heart health when tested as a “primary prevention” therapy, ...

The company has received a “limited number” of non-binding proposals, mostly from groups of financial investors, for a ...

The company is working on T cell engagers and other multifunctional antibodies, led by a prospect it believes might be ...

Wall Street analysts expect the subcutaneous version of Keytruda, which just launched this week, to help soften the blow when the original loses patent protection later this decade.

The Japanese pharmaceutical company, which had made cell therapy a priority a few years ago, aims to partner its work while ...

Medical meetings often feature important clinical trial results, making them barometers of biotech and pharma companies’ ...